Evidence map›Paper›PMID 40909739›Full record

ArticlebioRxiv : the preprint server for biology2025

A fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma.

Shoval Miyara, Shachaf Frenkel, Avi Mayo, Philippe Gascard, Michael Strasser, David Gibbs, Eviatar Weizman, Itay Ben Shalom, Yaniv Stein, Deng Pan and 19 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Shoval MiyaraDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-9003-046X
Shachaf FrenkelDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Avi MayoDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Philippe GascardDepartment of Pathology, University of California, San Francisco, CA, USA.ORCID 0000-0001-5912-5228
Michael StrasserInstitute for Systems Biology, Seattle, WA, USA.
David GibbsInstitute for Systems Biology, Seattle, WA, USA.
Eviatar WeizmanThe Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-6549-891X
Itay Ben ShalomDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Yaniv SteinDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-0331-772X
Deng PanDepartment of Pathology, University of California, San Francisco, CA, USA.
Joseph A CarusoDepartment of Pathology, University of California, San Francisco, CA, USA.
Veena SangwanDivision of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University Health Centre, Montreal, QC, Canada.
Nicholas BertosDivision of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University Health Centre, Montreal, QC, Canada.ORCID 0000-0001-5466-6076
Julie BerubeDivision of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University Health Centre, Montreal, QC, Canada.
Sophie Camilleri-BroetDepartment of Pathology, McGill University, Montreal, Quebec, Canada.
Spyridon OikonomopoulosMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, QC, Canada.
Haig DjambazianMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, QC, Canada.
Kfir Baruch UmanskyDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-0541-3069
Jacob ElkahalDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-0157-7162
Shimrit MayerDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-4634-3562
Pierre-Olivier FisetDepartment of Pathology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-4117-490X
Jiannis RagoussisMcGill Genome Centre and Department of Human Genetics, McGill University, Montreal, QC, Canada.ORCID 0000-0002-8515-0934
Miri AdlerDepartment of Genetics, Silberman Institute of Life Sciences; and Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0003-4687-7572
Eldad TzahorDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-5212-9426
Sui HuangInstitute for Systems Biology, Seattle, WA, USA.
Lorenzo FerriDivision of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University Health Centre, Montreal, QC, Canada.ORCID 0000-0003-3275-2584
Thea D TlstyDepartment of Pathology, University of California, San Francisco, CA, USA.ORCID 0000-0003-0903-1631
Ruth Scherz-ShouvalDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4570-121X
Uri AlonDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-6903-9956

Funding

Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic CancersR35CA197694 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TLSTY, THEA D · 2016 to 2022
$6.1M
Defining a Stromal Signature that Facilitates Progression of Lethal CancersR50CA211543 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GASCARD, PHILIPPE · 2019 to 2023
$1.2M
NCI NIH HHS R35 CA197694NCI NIH HHS R50 CA211543
6 · The paper itself

Abstract

The tumor microenvironment (TME) of chronic inflammation-associated cancers (CIACs) is shaped by cycles of injury and maladaptive repair, yet the principles organizing fibrotic stroma in these tumors remain unclear. Here, we applied the concept of hot versus cold fibrosis, originally credentialed in non-cancerous fibrosis of heart and kidney, to lung squamous cell carcinoma (LUSC), a prototypical CIAC. Single-cell transcriptomics of matched tumor and adjacent-normal tissue from 16 treatment-naive LUSC patients identified a cold fibrotic architecture in the LUSC TME: cancer-associated fibroblasts (CAFs) expanded and adopted myofibroblast and stress-response states, while macrophages were depleted. This macrophage-poor, CAF-rich stroma was maintained by CAF autocrine growth factor loops, including

Identifiers

PMID40909739
PMCPMC12407771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.